ECA-污染控制策略指南(中英文)-202202
VIP免费
1
Foundation
Fostering harmonisation
ofGMP/GDPregulations
How to Develop and Document a
Contamination Control Strategy
如何制定和编制污染控制策略
-ECA Task Force on Contamination Control Strategy-
-ECA 污染控制策略工作小组-
3
Foundation
Fostering harmonisation
ofGMP/GDPregulations
目录
1. Background 背景介绍 ..................................................................................................................... 4
2. Introduction 简介 ...............................................................................................................................5
3. Contamination Control Strategy (CCS )- the Elements listed in Annex 1 污染控制策略(CCS)
—附录1 中 所列的要素 ....................................................................................................................... 8
4. Development and Documentation of a Company 's CCS 公 司CCS 的开发和编制............. 10
5. Responsibilities /Ownership 职责/所有权 ..................................................................................... 27
6. Future challenges in the holistic evaluation of the CCS performance 对CCS 性能进行整体评
价的未来挑战 ....................................................................................................................................... 28
附 件....................................................................................................................................................... 30
附 件 1: 差 距 评 估 实 例 ( 非 详尽 无 遗 )............................................................................................. 30
附件2: CCS 内容表的例子 ............................................................................................................... 30
附 件 3: 污 染 控 制 策 略 文 件 的 模板 ( 示 例 ) ................................................................................... 30
Foundation
Fostering harmonisation
ofGMP/GDPregulations
4
1. Background 背景介绍
For pharmaceutical manufacturers and their suppliers,contamination of any kind that leads to product
or production losses represents a significant risk.As recent events in the past,such as foreign
particulate contamination
(https://www.fiercepharma.com/pharma/contaminant-moderna-covid-19-vaccine-vials-
found-japan-was-metallic-particles-report),have shown,this can lead to supply bottlenecks for
individual medicinal products or groups of medicinal products.
对于制药商及其供应商来说,导致产品或生产损失的任何形式的污染都代表着一种重大风险。
正如最近发生的事件,如外来微粒污染
(https://www.fiercepharma.com/pharma/contaminant-moderna-covid-19-vaccine-vials-found-japan-
was-metallic-particles-report) 所示,这可能导致个别药品或药品组的供应瓶颈。
Manufacturers should design their production facilities,equipment,and processes and implement
Quality Risk Management(QRM)to ensure appropriate contamination control to minimize or detect
contamination.Since measures affect different stages of a manufacturing process and often fall under
the responsibility of other departments(e.g.,quality control,quality assurance,or manufacturing),it
may not always ensure that the data obtained in the process,e.g.,from the original qualifications and
validations,process controls and ongoing environmental monitoring,are linked with each other.This
also applies to corrective and preventive actions that are often taken as a result of deviations and trend
analyses but are neither integrated into a strategy for a holistic view nor is there a linkage of all critical
control points and the evaluation of the effectiveness of all controls(design,procedures,technology,
and organization).However,a holistic view is proposed in the draft revision of Annex 1 version 12
(2020)for particulates,microbial,and pyrogen contamination.
制造商应设计其生产设施、设备和工艺,并实施质量风险管理 (QRM), 以确保适当的污
染控制,以尽量减少或检测污染。由于措施会影响到生产过程的不同阶段,而且往往由其
他部门负责(如QC、QA 或生产),因此可能并不总是能确保在这个过程中获得的数据,
如来自原始资格和验证、过程控制和持续环境监测的数据是相互联系的。这也适用于通常
是由于偏差和趋势分析而采取的CAPA, 但既没有被整合到整体策略中,也没有将所有关键
摘要:
展开>>
收起<<
1FoundationFosteringharmonisationofGMP/GDPregulationsHowtoDevelopandDocumentaContaminationControlStrategy如何制定和编制污染控制策略-ECATaskForceonContaminationControlStrategy--ECA污染控制策略工作小组-3FoundationFosteringharmonisationofGMP/GDPregulations目录1.Background背景介绍.......................................................
声明:如果您的权利被侵害,请联系我们的进行举报。
相关推荐
-
MSA-测量系统分析(MSA)作业指导书
2024-04-18 69 -
扭力测试仪操作规范
2024-05-09 43 -
AIAG-VDA-FMEA作业指导书VIP免费
2024-05-21 57 -
医疗器械产品无菌检验操作规程VIP免费
2024-07-06 72 -
泄漏电流测试仪操作规程VIP免费
2024-11-06 27 -
软件产品测评作业指导书VIP免费
2024-11-16 37 -
可重复使用诊疗器械、器具清洗质量监测标准操作规程VIP免费
2024-11-18 31 -
软件作业指导书VIP免费
2024-11-19 23 -
产品返工作业指导书(模板)VIP免费
2025-05-23 127 -
PCR实验室作业指导书VIP免费
2025-06-03 27
作者:多多猪
分类:专业资料
属性:29 页
大小:538.7KB
格式:PDF
时间:2025-11-04

